M17.1
Conditions
Interventions
Group 1: Study Group:
50% of the patients are randomised into this group.
The patients undergo a total knee arthroplasty.
During the operation the surgeon performs three injections of 50 ml of a mixt
Sponsors
Main-Kinzig-Kliniken, Anästhesie
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age > 18 years ASA I-III Total Knee Arthroplasty
Exclusion criteria
Exclusion criteria: Age III Trauma Unicompartimental Knee replacement Second look operations Allergy for used medication Missing informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative painscores. Pain scores (NRS - numeric rating scale) will be recorded directly after the operation and at defined time slots on the day of operation and on postoperative days 1 and 2. Pain scores are recorded for the anterior and posterior aspect of the knee, at rest and under movement separately. The maximum pain score will be recorded as well. | — |
Secondary
| Measure | Time frame |
|---|---|
| Knee range of motion in degree. This will be obtained by the physiotherapists during the fast track mobilisation training. Opioidconsumption in sum in mg. Theses data will be recorded together with the pain scores. The total opioid consumption consists of the postoperative injections in the recovery room and the PCA dosages. | — |
Countries
Germany
Contacts
Public ContactDirk Meininger
Main-Kinzig-Kliniken, Anästhesie
Outcome results
None listed